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Glasgow, UK; and 4Department of Anatomy and Developmental Cell Biology, Monash University, Clayton, Victoria, AustraliaIntroduction: X-linked Alport syndrome (OMIM 301050) is caused by COL4A5missense variants in 40% of
families. This study examined the effects of chemical chaperone treatment (sodium 4-phenylbutyrate) on
ﬁbroblast cell lines derived from men with missense mutations.
Methods: Dermal ﬁbroblast cultures were established from 2 affected men and 3 normals. Proliferation
rates were examined, the collagen IV a5 chain localized with immunostaining, and levels of the intra- and
extracellular chains quantitated with an in-house enzyme-linked immunosorbent assay. COL4A5 mRNA
was measured using quantitative reverse transcriptase polymerase chain reaction. Endoplasmic reticulum
(ER) size was measured on electron micrographs and after HSP47 immunostaining. Markers of ER stress
(ATF6, HSPA5, DDIT3), autophagy (ATG5, BECN1, ATG7), and apoptosis (CASP3, BAD, BCL2) were also
quantitated by quantitative reverse transcriptase polymerase chain reaction. Measurements were
repeated after 48 hours of incubation with 10 mM sodium 4-phenylbutyrate acid.
Results: Both COL4A5 missense variants were associated with reduced proliferation rates on day 6
(P ¼ 0.01 and P ¼ 0.03), ER enlargement, and increased mRNA for ER stress and autophagy (all P values <
0.05) when compared with normal. Sodium 4-phenylbutyrate treatment increased COL4A5 transcript
levels (P < 0.01), and reduced ER size (P < 0.01 by EM and P < 0.001 by immunostaining), ER stress
(p HSPA5 and DDIT3, all P values < 0.01) and autophagy (ATG7, P < 0.01). Extracellular collagen IV a5
chain was increased in the M1 line only (P ¼ 0.06).
Discussion: Sodium 4-phenylbutyrate increases collagen IV a5 mRNA levels, reduces ER stress and
autophagy, and possibly facilitates collagen IV a5 extracellular transport. Whether these actions delay end-
stage renal failure in men with X-linked Alport syndrome and missense mutations will only be determined
with clinical trials.
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International Reports (2017) 2, 739–748COL4A5 codes for the collagen IV a5 chain which
forms a heterotrimer with the a3 and a4 chains.4 The
resulting a3a4a5 network predominates in the
basement membranes of the glomerulus (GBM),
cochlea, lens capsule, and retina, which are all
abnormal in Alport syndrome.5–8 COL4A5 mutations
also affect the collagen IV a5 chain in the a5a5a6
network of the epidermis.9
More than 1200 different pathogenic variants have
been described in COL4A5 (www.LOVD.nl). Forty739
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glycine residue in the Gly-Xaa-Yaa collagenous
domain.10 Normal collagen biosynthesis includes
translational modiﬁcation and trimerization to form an
a3a4a5 protomer that is secreted extracellularly.
Missense mutations cause endoplasmic reticulum (ER)
retention of the unassembled or misfolded collagen
and its subsequent degradation. This is consistent
with the demonstration of the collagen IV a5 chain in
male Alport podocytes but its absence from affected
GBM.11 A compensatory increase in the a1a1a2
network, which is more susceptible to proteolysis,12
leads to GBM thinning, lamellation, and
vacuolation.13
In other collagen diseases, including those due to
mutant COL4A1 and COL4A2 genes, missense muta-
tions cause protein misfolding and retention within the
ER.14,15 The accumulation of misfolded protein results
in the unfolded protein response (UPR) and increased
ER stress. The stress response is both protective, by
enhancing the capacity for protein folding and
reducing translation,16 and damaging, by activating
protein degradation via the ER-associated degradation
system and/or autophagy.
Missense mutations in the collagen IV a1, a2
chain15,17 genes, and the a3 chain genes in autosomal
recessive Alport syndrome and thin basement mem-
brane nephropathy18 all activate the UPR and increase
ER stress. Other inherited diseases affecting the kidney
that are caused by abnormal protein folding include
Pierson syndrome (LAMB2) and focal segmental
glomerulosclerosis due to nephrin (NPHS1), podocin
(NPHS2), CD2AP, and aACTN4 mutations.19–24
Chaperones are small compounds that stabilize mis-
folded proteins and improve the protein-folding capac-
ity of cells, thereby increasing protein secretion and
reducing ER stress. Chemical chaperones represent
potential treatments for disease due to missense muta-
tions associatedwith the retention of misfolded proteins.
Sodium 4-phenylbutyrate (PBA) increases ER folding
capacity, stabilizes the folded protein, and facilitates
protein trafﬁcking25 as well as increasing ER-associated
degradation and decreasing autophagy.26 PBA is an
orally administered ammonia scavenger already in
clinical use for the treatment of urea cycle disorders.27
PBA treatment has been demonstrated to reduce
collagen IVa2 chain retention and associated ER stress in
COL4A2 missense mutant cell lines.15
This study examined the consequences of COL4A5
missense mutations on protein expression, ER stress,
autophagy and apoptosis, and cell proliferation in
primary ﬁbroblasts from males with X-linked Alport
syndrome, and the effects of treatment with the
chemical chaperone PBA.740METHODS
Study Subjects
Two men with X-linked Alport syndrome due to
COL4A5 missense mutations and 3 age-matched
nonhematuric normal subjects were studied. Both
affected men had functioning renal transplants.
This work was approved by the Northern Health
Human Research Ethics Committee according to the
principles of the Declaration of Helsinki, and all
participants provided signed, informed consent.
Cell Culture
Primary dermal ﬁbroblast cultures were established
from 4-mm skin punch biopsies from each subject. The
tissues were teased out, incubated with Dulbecco’s
modiﬁed Eagle’s medium (Invitrogen, Carlsbad, CA)
with 10% fetal bovine serum (Invitrogen), 1% peni-
cillin/streptomycin/l and 2 mM L-glutamine (Invi-
trogen) in 5% CO2, and ﬁbroblasts grown to conﬂuence
at 37 C.
Immunocytochemistry
Fibroblasts were cultured in chamber slides (BD Falcon
Slides, BD Biosciences, Bedford, MA), ﬁxed with
ice-cold acetone, and incubated with a 1:300 rabbit
polyclonal anticollagen IV a5 antibody (Covalab, Vil-
leurbanne, France), followed by a 1:300 dilution
of ﬂuorescein isothiocyanate goat anti-rabbit IgG
(Sigma-Aldrich, St. Louis, MO). Slides were examined
using a Zeiss microscope and photographed at 200
magniﬁcation.
Enzyme-Linked Immunosorbent Assay
Bovine GBM was puriﬁed as described previously28
and coated on plates at 20 mg/ml in phosphate-
buffered saline, pH 7.3, overnight at 4 C (Nunc
immunoplates). Plates were then blocked with 1%
bovine serum albumin (Boehringer Mannheim, Man-
nheim, Germany) in phosphate-buffered saline for 2
hours at room temperature. Concentrations of GBM
were determined in an inhibition assay performed as
follows. Twenty-ﬁve microliters of intracellular lysate
prepared from the supernates after microfugation, from
5 freeze-thaws in phosphate-buffered saline, or 25 ml of
the extracellular culture supernate, all corrected for cell
numbers, were preincubated with 25 ml of 1:50 dilution
rabbit anticollagen IV a5 antibody in phosphate-
buffered saline/TWEEN (Sigma-Aldrich) at room tem-
perature for 30 minutes and then added to GBM-coated
wells in duplicate for 1 hour at room temperature. The
plates were then incubated with a 1:1000 dilution of
alkaline phosphatase–conjugated goat anti-rabbit IgG
(Sigma-Aldrich) for 30 minutes and p-nitro-
phenylphosphate (Sigma-Aldrich) for 15 minutes atKidney International Reports (2017) 2, 739–748
D Wang et al.: Mutation-Directed Therapy TRANSLATIONAL RESEARCHroom temperature. The absorbance was measured at
405 nm (Thermo Scientiﬁc Fisher plate reader), and the
concentrations were determined from a standard curve
of serial dilutions of GBM with ﬁnal concentrations of
0.03 to 30 mg/ml.
Quantitative Polymerase Chain Reaction
Total RNA was extracted from cells using an RNA
Isolation Kit (Zymo Research, Irvine, CA). RNA integ-
rity was assessed after agarose gel electrophoresis, and
the concentrations were measured spectrophotometri-
cally (Nanodrop Technologies, Wilmington, DE). The
samples were subjected to DNase treatment using a
DNA-free kit (Ambion, Inc., Austin, TX), and 1 mg
from each sample reverse-transcribed using oligo dT
and a SuperScript III First Strand Synthesis System Kit
(Invitrogen).
Samples were then assayed for COL4A5 transcripts,
using the ﬂuorescent intercalating agent SYBR Green 1
(Qiagen, Hilden, Germany), speciﬁc primers (Life
Technologies, Mulgrave, Victoria, Australia)
(Supplementary Tables S1 and S2), and the ABI 7500
real-time PCR System (Applied Biosystems, Waltham,
MA). Individual reactions comprised 5 ml of 2
QuantiTect SYBR Green RT-PCR Master Mix (Qiagen),
0.7 ml each of 20 ng/ml sense and antisense primer, and
2 ml of 100 ng/ml cDNA template, in a total volume of
10 ml. The threshold cycle value was calculated at the
end of each run using glyceraldehyde-3-phosphate
dehydrogenase as the internal control and software
provided by the manufacturer. Each sample was
examined in duplicate and the assays performed in
triplicate. The results were compared with expression
in the 3 normal male ﬁbroblast cell lines in different
experiments.
Growth Curves
Fibroblast proliferation was examined over 6 days.
Five  104 cells in 2 ml of Dulbecco’s modiﬁed Eagle’s
medium were seeded in each well of a 6-well culture
plate (BD Falcon, BD Biosciences) and allowed to adhere
for 24 hours. Cells were counted the next day (time 0),
and then each 24 hours. Cells were counted after
trypsinization using a hemocytometer and an Olympus
CKX41 microscope.Quantitation of the UPR, Cell Stress, Apoptosis,
and Autophagy Pathways
Levels of mRNA corresponding to markers of the UPR
(cell stress), pro- and antiapoptotic pathways, and auto-
phagy, were quantitated using primers (Supplementary
Table S2), and quantitative polymerase chain reaction,
as described previously.Kidney International Reports (2017) 2, 739–748ER Size and Colocalization Experiments
ER size was examined in the primary dermal ﬁbroblasts
using 2 methods: electron microscopy and immuno-
cytochemistry. For electron microscopy, ﬁbroblast
cell pellets were ﬁxed in 2.5% chilled glutaraldehyde
(Sigma-Aldrich), postﬁxed in 2% OsO4 (Sigma-
Aldrich), and prepared routinely. The grids were
examined, and images were captured with a trans-
mission electron microscope (Phillips CM 120BioTWIN,
Eindhoven, The Netherlands). ER size was measured
using ImageJ software (https://imagej.nih.gov/ij/), and
ER size was determined in consecutive cells that were
measured and averaged.
For immunostaining, ﬁbroblasts were grown on
coverslips and processed for immunohistochemistry,
but with the additional antibodies (antiHSP47, 1:400,
Enzo Life Sciences, Farmingdale, NY). ER volume from
50 consecutive ﬁelds were quantiﬁed again using
ImageJ software.
Treatment With the Chemical Chaperone PBA
One ﬂask of cells was left untreated, and the others
were incubated with 10 mM of PBA (Sigma-Aldrich)
for 48 hours at 37 C, and the cells were then harvested.
In general, data were obtained in duplicate from 3
independent experiments for each cell line.
Statistical Analyses
Data are provided as mean  SD, and statistical ana-
lyses were performed using an unpaired t test. Differ-
ential mRNA expression was analyzed by analysis of
variance. Statistical analyses were performed using
Graph Pad Prism, version 5. A P value <0.05 was
considered signiﬁcant.
RESULTS
Fibroblast cell lines were established from the skin
biopsy specimens from 2 men with X-linked Alport
syndrome due to Gly substitutions (Table 1). Male 1
(G908R) had early-onset renal failure together with
lenticonus and central retinopathy, and in Male 2
(G624D), renal failure had developed at middle age
with hearing loss but no ocular features.
Collagen IV a5 Chain Expression in
Affected Fibroblasts
The collagen IV a5 chain was demonstrated pre-
dominantly in a perinuclear location, corresponding
to the ER, in the normal and affected male ﬁbroblasts
(Figure 1a, left and right, respectively). There was
less intracellular a5 chain in the cell line from Male 1
by immunocytochemistry (the cell line from Male 2
was not examined) and less than normal in both cell741
Table 1. Clinical features in males with X-linked Alport syndrome and missense mutations
Male Sex, age (yr) Exon Mutation Renal features Age at ESRF (yr) Hearing loss Lenticonus Central retinopathy Peripheral retinopathy
1 M, 48 32 p.G908R RF 14 Yes Yes Yes Yes
2 M, 54 25 p.G624D RF 46 Yes Yes No Yes
ESRF, end-stage renal failure; H, hematuria; N/A, applicable; P, proteinuria; RF, renal failure.
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assay (P < 0.0001 and P ¼ 0.003, respectively)
(Figure 1b).
There was no difference in the levels of collagen IV
a5 mRNA in the affected Male 1 and Male 2 cell lines
compared with normal by quantitative polymerase
chain reaction (both P values were nonsigniﬁcant)
(Figure 1c).
One explanation for the reduced levels of intracel-
lular collagen IV a5 chain but normal mRNA levels
in the affected male cell lines is that the collagen
IV a5 chain was degraded, at least in part,
intracellularly.b
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Figure 1. Effect of COL4A5 missense mutations on collagen IV a5 chain ex
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742Cell Proliferation
Both affected male ﬁbroblast cell lines grew more
slowly than the mean of 3 normal cell lines measured
at day 6 (P ¼ 0.03, P ¼ 0.01, Figure 2a). The cell line
from Male 1 grew more slowly than that from Male 2.
This cell line corresponded to the mutation associated
with earlier onset renal failure.
ER Stress, Autophagy, and Apoptosis
Affected ﬁbroblasts in both cell lines demonstrated
increased levels of mRNA coding for the UPR/ER stress
(ATF6, HSPA5, and DDIT3) compared with the 3
normals by quantitative polymerase chain reactionb
c
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Figure 2. Effect of COL4A5 missense mutations on cell proliferation,
endoplasmic reticulum (ER) stress, autophagy, and apoptosis. (a)
Affected fibroblast cell lines from Male 1 and Male 2 grew more
slowly than 3 normal cell lines over 6 days (P ¼ 0.01 and P ¼ 0.03
compared with the mean normal value at day 6, respectively). Cell
numbers were measured in duplicate. (b) Both affected cell lines
had increased levels of mRNA coding for markers of the unfolded
protein response (UPR)/ER stress (ATF6, HSPA5, and DDIT3), and
autophagy (ATG7). The cell line from Male 1 also had increased
ATG5 and BECN1 (autophagy) as well as BAD and CASP3 (proa-
poptosis) mRNA. These results represent the mean  SD of 3
experiments performed in duplicate and compared with the results
in a normal male standardized to 1.00.
0
1
2
3
4
Male 1 PBA Male 2 PBA
Re
la
?
ve
 m
RN
A 
ex
pr
es
si
on
 
*** ***
Figure 3. Effect of sodium 4-phenylbutyrate (PBA) on collagen IV a5
mRNA expression. PBA incubation increased the expression of
collagen IV a5 mRNA in ﬁbroblast cell lines from both Male 1 and
Male 2 cell lines compared with normal (P < 0.001 in both cases).
These results represent the mean  SD of 3 experiments performed
in duplicate. ***P < 0.001.
D Wang et al.: Mutation-Directed Therapy TRANSLATIONAL RESEARCH(Male 1, P < 0.05 or P < 0.01; Male 2, all P values <
0.01) (Figure 2b).
ER stress results in activation of the protein degra-
dation pathways such as autophagy in an attempt to
restore ER and cell homeostasis. Both cell lines had
increased ATG7 mRNA levels (P < 0.05 and P < 0.01)
and BECN1 mRNA (P < 0.01 and P < 0.05), respec-
tively, compared with normal.
Apoptotic marker mRNA (CASP3 and BAD) were also
increased in the cell line from Male 1 (P < 0.05). There
was no increase in the proapoptotic marker mRNA, and
there was a reduction in the antiapoptotic marker BCL2
mRNA in the cell line from Male 2 (P < 0.01).
Both missense mutations affected autophagy markers
more than markers of apoptosis.
PBA Treatment and Collagen IV a5 mRNA Level
PBA treatment increased the level of collagen IV a5
mRNA in cell lines from both Male 1 (P < 0.001) andKidney International Reports (2017) 2, 739–748Male 2 (P < 0.001) (Figure 3) and in a normal cell line
(data not shown).
PBA Treatment and Collagen IV a5 Chain
Location
PBA treatment produced fewer consistent effects on
collagen IV a5 transport. In the cell line from Male 1,
intracellular collagen IV a5 levels were reduced
(P ¼ 0.002), and there was a trend toward higher
extracellular collagen IV a5 levels (P ¼ 0.06), but this
effect was not seen in the cell line from Male 2
(Figure 4).
PBA Treatment and ER Size
ER on electron micrographs were larger in affected
ﬁbroblasts from Male 1 than normal cells (P < 0.01) and
became smaller after PBA treatment (P < 0.01)
(Figure 5a and b). The reduction in ER size after PBA
treatment was conﬁrmed independently with HSP47
colocalization by cytochemistry (Figure 5c) in cell lines
from both Male 1 and Male 2 (P < 0.001 and P < 0.001,
respectively) compared with a normal cell line
(Figure 5d).
PBA Treatment and ER Stress, Autophagy
and Apoptosis
Levels of mRNA coding for the UPR (ATF6, HSPA5,
and DDIT3) were all less in the cell lines from Male 1
after PBA treatment (P < 0.01) (Figure 6a and b). Levels
of autophagy mRNA (ATG5 (P < 0.05), BECN1
(P < 0.010) and ATG7 (all P values < 0.01), and for the
proapoptosis markers (CASP3 and BAD) were also less
(all P values < 0.01).
Levels of mRNA coding for the UPR (HSPA5 and
DDIT3), for autophagy (ATG5) and the proapoptosis
marker (CASP3) in the cell line from Male 2 were all
lower after PBA treatment (all P values < 0.01)
(Figure 6a and b).743
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Figure 4. Effect of sodium 4-phenylbutyrate (PBA) incubation on
collagen IV a5 chain levels. (a) The normal cell line demonstrated no
difference in intra- or extracellular collagen IV a5 levels after PBA
treatment (P ¼ 0.13 and P ¼ 0.95, respectively). (b) PBA treatment
reduced intracellular collagen IV a5 levels (P ¼ 0.002) and demon-
strated an increased trend in extracellular collagen IV a5 (P ¼ 0.06)
in the M1 cell line. (c) PBA treatment increased intracellular
collagen IV a5 levels (P < 0.0001), but extracellular levels were not
different (P ¼ 0.10) in the M2 cell line. These results represent
the mean  SD of 3 experiments performed in duplicate. ext,
extracellular; int, intracellular.
TRANSLATIONAL RESEARCH D Wang et al.: Mutation-Directed TherapyIn summary, PBA treatment reduced mRNA levels
for the UPR (HSPA5 and DDIT3), autophagy (ATG7),
and proapoptotic markers (CASP3) in both affected
male cell lines (all P values < 0.01). The effect of PBA
on the autophagy marker ATG7 was most pronounced
and consistent in both cell lines.
DISCUSSION
This study demonstrated that missense mutations in
cell lines from men with X-linked Alport syndrome are
associated with increased ER size and stress, increased
autophagy, and reduced cell proliferation. These effects
varied with different mutations. Treatment with the744chemical chaperone PBA consistently decreased ER size
and stress and reduced autophagy. PBA treatment also
increased collagen IV a5 transcript levels and some-
times extracellular collagen IV a5 chain levels. These
results indicate novel pathogenetic mechanisms in
Alport syndrome and further targets for therapy. In
particular, PBA appears to have several potentially
useful actions for the treatment of X-linked Alport
syndrome caused by missense mutations.
As with other inherited collagen diseases, most
COL4A5 missense mutations change a Gly residue.29
Individual mutations differ in their clinical conse-
quences depending on their locationwithin the gene, the
substituting residue, and the effects of modifying
genes.30,31 We studied cell lines with different Gly
substitutions. One was associated clinically with early-
onset renal failure and extrarenal features, consistent
with a severe phenotype (Male 1). In the corresponding
cell line, we demonstrated increased ER stress and
autophagy and less cell proliferation. These features
were all more pronounced than in the cell line associated
with isolated late-onset renal failure. This is consistent
with missense mutations affecting the clinical pheno-
type through multiple mechanisms.
Disease pathogenesis in Alport syndrome has been
attributed to the loss of the collagen IV a5 chain and
the a3a4a5 heterotrimer and a compensatory increase
in the proteolytically susceptible a1a2 network.32
Protein leakage through the damaged GBM and reab-
sorption is the major initiator of tubulointerstitial
damage and progressive renal failure.32 The nearly
normal collagen IV a5 mRNA levels but reduced
intracellular chain in the cell line from Male 1 suggest
degradation possibly by ER-associated decay or from
increased autophagy. This result was unexpected
because other studies of collagen missense mutations
suggest intracellular collagen IV chain retention.18
However, the collagen IV a5 reduction was conﬁrmed
independently by immunocytochemistry.
Increased ER stress has been demonstrated in other
inherited collagen diseases18,33,34 and, in particular,
collagen IV diseases.15,35 It is typically associated with
autophagy more than apoptosis.36 This was conﬁrmed
in our study.
The reduction in intracellular collagen IVa5 level
but increased ER size in the cell line from Male 1 may
be explained by ER size increasing even before the
development of ER stress in order to counteract it.37
Males with COL4A5 missense mutations not only
have abnormal glomerular membranes but also
abnormal membranes in the skin, aorta, Bowman’s
capsule, and testes. Loss of the a5a5a6 network
contributes to the rare associations of aortic aneurysms
and rupture in Alport syndrome.38 Affected males withKidney International Reports (2017) 2, 739–748
PBA
c d
ER
lu
m
en
w
id
th
(μm
)
Media PBA Media PBA
0.0
0.2
0.4
0.6
Male 1Normal
* * * *
Media only PBA 
Male 1
Normal
a b
0
400
800
1200
1600
2000
Male 1 PBA Male 2 PBA
Fi
br
ob
la
st
 E
R 
si
ze
 (A
U
)
***
***
Figure 5. Effect of sodium 4-phenylbutyrate (PBA) treatment on endoplasmic reticulum (ER) size. (a,b) ERs on electron micrographs were larger in
affected ﬁbroblasts from Male 1 than normal cells (P < 0.01) and became smaller after PBA treatment (P < 0.01). (c,d) The reduction in ER size
after PBA treatment was confirmed with HSP47 colocalization by cytochemistry in cell lines from both Male 1 and Male 2 (P < 0.001 and P <
0.001, respectively). These results represent the mean  SD of 3 experiments performed in duplicate. **P < 0.01, ***P <0.001. AU, arbitrary units.
D Wang et al.: Mutation-Directed Therapy TRANSLATIONAL RESEARCHX-linked disease have skin abnormalities, with dis-
continuities in the lamina densa, epidermal thinning,
duplication, and blebs.39 This is identical to those seen
with COL4A1 and COL4A2 mutations in which the
epidermis lacks the a1a1a2 network.15
We studied primary human ﬁbroblasts rather than
podocytes because of their accessibility. Occasionally,
fresh Alport kidneys and hence podocytes are available
for study, but these are not necessarily from in-
dividuals with missense mutations nor, indeed, from
individuals whose mutations are known. Males with X-
linked Alport syndrome already have scarred kidneys
by the time they reach renal failure in their third or
fourth decade, and, later, renal transplantation means
that any native podocytes in their urine are contami-
nated with desquamated cells from the allograft. In
addition, studies using affected ﬁbroblasts are likely to
be more informative than transfected cell lines because
they avoid experimentally-induced ER stress that may
confuse the results. Fibroblasts also have this advan-
tage over inducible pluripotent stem cells derived fromKidney International Reports (2017) 2, 739–748affected skin biopsies. Although epidermal ﬁbroblasts
lack the a3a4a5 network and, thus, the effects of the
COL4A5 mutations can only be examined in the
a5a5a6 heterotrimer, the mutation effects are likely to
be the same in both networks.
PBA treatment had multiple different effects in the
Alport cell lines. Chaperones typically facilitate the
transport of the target protein to their functional sites,
but collagen IV levels are also affected by both ER stress
and ER-associated degradation. Collagen IV a5 mRNA
expression increased in both lines, mRNA for ER stress
and autophagy markers were reduced, and extracellular
collagen IVa5 chain was increased in 1 cell line. The
PBA-induced mRNA increase has been described pre-
viously,40 but did not, in this study, consistently in-
crease the extracellular collagen IV a5 levels.
Chaperone therapy represents a potential treatment
for X-linked Alport syndrome caused by missense
mutations through reducing ER stress. ER stress in
podocytes is a major determinant of proteinuria,41 and
ER stress is pathogenetic in other diseases including745
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Figure 6. Effect of sodium 4-phenylbutyrate (PBA) treatment on endoplasmic reticulum (ER) stress, autophagy, and apoptosis. (a) Levels of
mRNA coding for markers for the unfolded protein response (UPR)/ER stress (ATF6, HSPA5, and DDIT3) and autophagy (ATG, BECN1, and ATG7)
were reduced after PBA treatment in cell lines from both Male 1 and Male 2. Levels of mRNA for CASP3 and BAD (proapoptosis markers) were
also reduced after PBA treatment. (b) Levels of mRNA for the UPRs (HSPA5 and DDIT3) and autophagy (ATG7) and the proapoptosis marker
(CASP3) were all reduced after PBA treatment in the cell line derived from Male 2. These were also corrected with PBA treatment. These
results represent the mean  SD of 3 experiments performed in duplicate. *P < 0.05, **P < 0.01.
TRANSLATIONAL RESEARCH D Wang et al.: Mutation-Directed Therapyhereditary angiopathy with nephropathy, aneurysms,
and muscle cramps syndrome and metaphyseal chon-
drodysplasia, which are caused by collagen IV and X
mutations, respectively.42 Treatment with PBA is likely
to reduce ER stress in vivo in Alport syndrome and,
hence, proteinuria, and further delay the onset of end-
stage renal failure.746PBA is probably the most commonly used chaperone
experimentally and clinically, but other chaperones
may be equally or more efﬁcacious.22 Chaperones
typically vary in their effects for different mutations,
depending on the amount of protein misfolding.20 This
study suggests that even similar mutations, such as
glycine substitutions in the collagenous domain, haveKidney International Reports (2017) 2, 739–748
D Wang et al.: Mutation-Directed Therapy TRANSLATIONAL RESEARCHdifferent effects on ER stress and different levels of
responsiveness to PBA. It may be difﬁcult to predict
who will respond to chaperone treatment.
Chemical chaperone treatment may still have dele-
terious effects, for example, where the incorporation of
an abnormal collagen IVa5 chain damages the basement
membrane structure. There are no apparent conse-
quences from coincidental effects on passenger
missense mutations from experience in the treatment of
the urea cycle disorders. Animal studies indicate that
treatment can partially reverse the Alport glomerular
membrane defect, even after damage is established.43
Understanding the direct clinical outcomes of
manipulating ER stress signals encourages a more
rational approach to the development of therapies for
inherited glomerular disease. The major risk of Alport
syndrome is renal failure, but this can be treated
relatively safely with transplantation, and any new
therapy must be evaluated against this standard. We
already have safe, effective treatments in the form of
angiotensin-converting enzyme inhibitors to delay
end-stage renal failure.44 However, chaperones may
further extend the time to renal failure and delay the
need for dialysis, which in itself is a highly valuable
outcome. Chaperone treatment may also be useful as
adjunctive therapy for other currently untreatable
manifestations of Alport syndrome, such as the rare
aortic aneurysms,38 retinal maculopathy,45 and rapidly
progressive hearing loss in children.
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